Recurrent atrial fibrillation after high-dose methylprednisolone therapy in a girl with lupus-associated hemophagocytic syndrome

Lupus

Volumn 20, Issue 8, 2011, Pages 871-875

  Yamamura, K ^a   Ohga, S ^a   Nishiyama, K ^a   Doi, T ^a   Tsutsumi, Y ^a   Ikeda, K ^a   Fujishima, A ^b   Takada, H ^a   Hara, T ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY HOSPITAL   (Japan)

Author keywords

Atrial fibrillation; Hemophagocytic syndrome; High dose methylprednisolone therapy; Systemic lupus erythematosus

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CALCIUM; CATECHOLAMINE; CREATINE KINASE; CREATININE; CYCLOSPORIN A; FERRITIN; FIBRINOGEN; FRESH FROZEN PLASMA; FUROSEMIDE; GAMMA INTERFERON; HEMOGLOBIN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; LA ANTIBODY; LACTATE DEHYDROGENASE; METHYLPREDNISOLONE; MIZORIBINE; NEUTROPHIL CYTOPLASMIC ANTIBODY; PILSICAINIDE; POTASSIUM; PREDNISOLONE; RO ANTIBODY; SODIUM; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANTIBODY TITER; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DISEASE ACTIVITY; DRUG PULSE THERAPY; ELECTROCARDIOGRAPHY; FACE ERYTHEMA; FEMALE; GLOMERULONEPHRITIS; HEART ATRIUM FIBRILLATION; HEMOPHAGOCYTIC SYNDROME; HEPATOSPLENOMEGALY; HOSPITAL ADMISSION; HUMAN; HYPOCOMPLEMENTEMIA; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LEUKOCYTE COUNT; LUPUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME; LUPUS ERYTHEMATOSUS NEPHRITIS; MOON FACE; PARTIAL THROMBOPLASTIN TIME; PHYSICAL EXAMINATION; PR INTERVAL; PRIORITY JOURNAL; PROTHROMBIN TIME; QT INTERVAL; REMISSION; SINUS RHYTHM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTE COUNT; UREA NITROGEN BLOOD LEVEL;

ADOLESCENT; ATRIAL FIBRILLATION; BONE MARROW; C-REACTIVE PROTEIN; CATECHOLAMINES; CYTOKINES; FEMALE; GLUCOCORTICOIDS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; METHYLPREDNISOLONE;

EID: 80052700279     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203310392429     Document Type: Article

References (20)

1. Carvalheiras G, Anjo D, Mendonça T, Vasconcelos C, Farinha F. Hemophagocytic syndrome as one of the main primary manifestations in acute systemic lupus erythematosus - case report and literature review. Lupus 2010; 19: 756-761.
2. Boos CJ, Lip GY. Inflammation and atrial fibrillation: cause or effect? Heart 2008; 94: 133-134. (Pubitemid 351211714)
3. Sata N, Hamada N, Horinouchi T, et al. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation? Jpn Heart 2004; J 45: 441-445. (Pubitemid 41518887)
4. Henningsen KM, Therkelsen SK, Bruunsgaard H, Krabbe KS, Pedersen BK, Svendsen JH. Prognostic impact of hs-CRP and IL-6 in patients with persistent atrial fibrillation treated with electrical cardioversion. Scand J Clin Lab Invest 2009; 69: 425-432.
5. Hak Ł, Myśliwska J, Wieckiewicz J, Szyndler K, Siebert J, Rogowski J. Interleukin-2 as a predictor of early postoperative atrial fibrillation after cardiopulmonary bypass graft (CABG). J Interferon Cytokine Res 2009; 29: 327-332.
6. Frustaci A, Chimenti C, Bellocci F, Morgante E, Russo MA, Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 1997; 96: 1180-1184. (Pubitemid 27344221)
7. Dernellis J, Panaretou M. Relationship between C-reactive protein concentrations during glucocorticoid therapy and recurrent atrial fibrillation. Eur Heart J 2004; 25: 1100-1107. (Pubitemid 38842447)
8. Van der Hooft CS, Heeringa J, Brusselle GG, et al. Corticosteroids and the risk of atrial fibrillation. Arch Intern Med 2006; 166: 1016-1020.
9. Aslam AK, Vasavada BC, Sacchi TJ, Khan IA. Atrial fibrillation associated with systemic lupus erythematosus and use of methylprednisolone. Am J Ther 2001; 8: 303-305. (Pubitemid 33753126)
10. McLuckie AE, Savage RW. Atrial fibrillation following pulse methylprednisolone therapy in an adult. Chest 1993; 104: 622-623. (Pubitemid 23229548)
11. Moretti R, Torre P, Antonello RM, Zorzon M, Cazzato G. Recurrent atrial fibrillation associated with pulse administration of high doses of methylprednisolone: a possible prophylactic treatment. Eur J Neurol 2000; 7: 130. (Pubitemid 32268753)
12. Ueda N, Yoshikawa T, Chihara M, Kawaguchi S, Niinomi Y, Yasaki T. Atrial fibrillation following methylprednisolone pulse therapy. Pediatr Nephrol 1988; 2: 29-31. (Pubitemid 18062342)
13. Seferović PM, Ristić AD, Maksimović R, et al. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology (Oxford) 2006; 45(Suppl 4): iv39-42. (Pubitemid 44446761)
14. Halonen J, Halonen P, Jarvinen O, et al. Corticosteroids for the prevention of atrial fibrillation after cardiac surgery: a randomized controlled trial. JAMA 2007; 297: 1562-1567. (Pubitemid 46588369)
15. Chikanza C, Fernandes L. Arrhythmia after pulse methylprednisolone therapy. Br J Rheumatol 1991; 30: 392-393.
16. Lambotte O, Khellaf M, Harmouche H, et al. Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosusassociated hemophagocytic syndrome. Medicine (Baltimore) 2006; 85: 169-182. (Pubitemid 43833015)
17. Hall ED, Plaster M, Braughler JM. Acute cardiovascular response to a single large intravenous dose of methylprednisolone and its effects on the responses to norepinephrine and isoproterenol. Proc Soc Exp Biol Med 1983; 173: 338-343. (Pubitemid 13070567)
18. Fujimoto S, Kondoh H, Yamamoto Y, Hisanaga S, Tanaka K. Holter electrocardiogram monitoring in nephrotic patients during methylprednisolone pulse therapy. Am J Nephrol 1990; 10: 231-236. (Pubitemid 20305002)
19. Kobayashi I, Yamada M, Kawamura N, Kobayashi R, Okano M, Kobayashi K. Platelet-specific hemophagocytosis in a patient with juvenile dermatomyositis. Acta Paediatr 2000; 89: 617-619. (Pubitemid 30643429)
20. Takizawa Y, Maruyama J, Setoguchi K. Cyclosporin rapidly diminished a severe lupus-associated macrophage association syndrome refractory to pulsed methylprednisolone and intravenous immunoglobulin. Scand J Rheumatol 2009; 38: 492-494.